Jain Global’s AstraZeneca AZN Stock Holding History

Jain Global’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,225	Closed	-$341K	–	1230
2025 Q3	$341K	Buy	+2,225	New	+$337K	﹤0.01%	794
2025 Q2	–	Sell	-21,417	Closed	-$3.15M	–	1193
2025 Q1	$3.15M	Buy	+21,417	New	+$3.1M	0.04%	292

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jain Global's AZN Position: Q4 2025 in Review

Jain Global sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 2,225 shares — an estimated $341K sold.

Jain Global first reported a position in AZN in Q1 2025 and held it in 2 quarters. The position peaked at $3.15M in Q1 2025. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

Jain Global reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
Jain Global sold 2,225 AstraZeneca shares in Q4 2025, an estimated $341K.
Jain Global first reported a position in AstraZeneca in Q1 2025 and held it in 2 quarters.
Jain Global's AstraZeneca position peaked at $3.15M in Q1 2025.
1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Jain Global's 13F filing for Q4 2025, filed 17 Feb 2026.